FILTERED RESULTS
FILTERS
Ads Top
DARK MODE
CHART
MCap $2.8T -0.2%24h Vol $87.8T +2.8%Fear & Greed 53/100Alts Index 51/100
BTC.D 59.4% +0.1%Stable.D 9.6% 0%ETH.D 10.7% 0%Others.D 20.3% -0.1%
WAL$0.0569+37.39%•Q$0.0496+27.97%•BTW$2.347+23.28%•AI$0.1028+20.01%•PRL$1.905+14.73%•DEEP$0.0238+12.15%•PYTH$0.0836+5.76%•TRAC$0.4518+5.52%•A$0.1035+4.14%•FLUID$2.445+4.13%•
GRASS$0.6139-16.04%•BAT$0.1684-13.59%•ZAMA$0.0676-13%•CHIP$0.0502-11.85%•OP$0.1406-10.38%•SYRUP$0.2077-10.18%•STRK$0.0772-9.66%•JTO$0.4817-9.51%•CC$0.1144-8.48%•RAY$1.876-8.48%•
Top movers 24h
    Filters
      Coins
      Sentiment
      Impact
      Search
      FILTERED RESULTS

        

      Upgrade your plan
      Dashboard

      Nvidia-backed AI drug company Iambic raises $150 million in US IPO

      PANews, October 15 — According to Bloomberg, Iambic Therapeutics, an AI drug company in which Nvidia holds a stake, issued approximately 9.38 million shares at $16 per share, raising $150 million in a US IPO. The pricing was at the midpoint of the $15 to $17 range, corresponding to a market value of about $758 million. The company is expected to begin trading on Nasdaq on October 15 under the ticker IAM, and the proceeds will advance three early-stage cancer drug candidates. ARK and Druckenmiller's family office had previously indicated interest in subscribing for up to $60 million combined.


      Source: PANews
      .

      Terra Founder Do Kwon Sentenced to 15 Years in Prison for Fraud